RCM
ACHV icon

Requisite Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Requisite Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50,000
Closed -$419K – 63
2020
Q3 		$419K Hold
50,000
– – 0.15% 38
2020
Q2 		$397K Buy
+50,000
New +$399K 0.15% 42

Other funds holding ACHV

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HR
Hayden Royal Charlotte, North Carolina $42.7M AUM 33.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Requisite Capital Management's ACHV Position: Q4 2020 in Review

Requisite Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2020, closing a stake of 50,000 shares — an estimated $419K sold.

Requisite Capital Management first reported a position in ACHV in Q2 2020 and held it in 2 quarters. The position peaked at $419K in Q3 2020. 16 funds tracked by Wall St. Rank hold ACHV as of Q4 2020.

  • Requisite Capital Management reported no remaining Achieve Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Requisite Capital Management sold 50,000 Achieve Life Sciences shares in Q4 2020, an estimated $419K.
  • Requisite Capital Management first reported a position in Achieve Life Sciences in Q2 2020 and held it in 2 quarters.
  • Requisite Capital Management's Achieve Life Sciences position peaked at $419K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2020.

Based on Requisite Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.